Kidney transplantation – be aware of TCC

Plasma TCC (sC5b-9) is associated with both patient and kidney long-time survival.
Nephrologists from aHUS and OUS Rikshospitalet have together with complementologists from NCRG recently presented data in Front Immunol showing data in 900 patients over a 10-year period that increased plasma TCC levels obtained in a stable period at 10 weeks after transplantation was associated with patient survival, graft survival and with death-censored graft loss.
Plasma TCC has again strengthened its position as an important marker in disease pathophysiology, adding another possible indication for complement therapeutic in the future.
Bartlomiej J. Witczak and Søren E. Pieschke were 1st and 2nd authors, and Anders Åsberg and Tom E. Mollnes shared the last authorship.
Here is the link to all authors and the paper – released by Frontiers and will soon be available on PuMed:
Similar News

Bridging the Gap: Rapid Bedside Complement Testing Brings Lab Innovation to the ICU
Tam Cung and Andreas Barratt-Due in the NCRG has published a paper using a point-of-care assay to detect complement activation...
Read more
Two Norwegian anesthesiologists in NCRG became professors at the University of Oslo
Søren Erik Pischke was recruited to NCRG as a postdoc in 2014 when he got the prestigious Young Investigators...
Read more
Steinar Kristiansen defended his PhD thesis
Fra venstre: Hovedveileder Tom Eirik Mollnes, biveileder Erik Waage Nielsen, disputasleder Ellinor Haukland, overlege ph.d. Steinar Kristiansen, 1. opponent Olav...
Read more